Rights and permissions
About this article
Cite this article
Drug costs rise despite value-for-money approach in Australia. Pharmacoecon. Outcomes News 317, 2 (2001). https://doi.org/10.1007/BF03269386
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269386